The role of parathyroid hormone-related protein (PTHrP) in fetal calcium homeostasis and placental calcium transport was examined in mice homozygous for the deletion of the PTHrP gene (PTHrP −/− null; NL) compared to PTHrP +/+ (wild-type; WT) and PTHrP +/− (heterozygous; HZ) littermates. Fetal blood ionized calcium was significantly reduced in NL fetuses compared to WT and HZ groups at 18 days of pregnancy (dp) with abolition of the fetomaternal calcium gradient. In situ placental perfusion of the umbilical circulation at 18 dp was used to measure unidirectional clearance of 45 Ca across the placenta in maternofetal ( Ca K mf ) and fetoplacental ( Ca K fp ) directions; Ca K fp was < 5% of Ca K mf for all genotypes. At 18 dp, Ca K mf across perfused placenta and intact placenta ( Ca K mf(intact) ) were similar and concordant with net calcium accretion rates in vivo.
hypercalcaemia of the fetus relative to its mother, a feature of all species studied (Sibley & Boyd, 1988; Atkinson et al. 2006) .
Ca J fm is thought to be a diffusional process (Husain et al. 2004) .
In common with other calcium transporting epithelia, calcium transport across the placenta could plausibly involve three main steps (Belkacemi et al. 2005; Atkinson et al. 2006) : firstly, diffusion into the trophoblast from maternal plasma down an electrochemical gradient through epithelial Ca 2+ channels of the transient receptor potential (TRP) gene family; secondly, transfer across the trophoblast cytoplasm bound to the calcium binding protein calbindin-D 9K (Glazier et al. 1992) ; and, thirdly, active extrusion into the fetal compartment via plasma membrane Ca 2+ -ATPase (PMCA) localized to the fetal facing basal plasma membrane (Fisher et al. 1987; Borke et al. 1989) . Over the last third of gestation, gene and protein expression for calbindin-D 9K increases markedly in both mouse and rat placenta (Mathieu et al. 1989; Glazier et al. 1992; Hamilton et al. 2000; An et al. 2004) whereas rat placental Ca 2+ -ATPase expression shows only a 2-to 3-fold increase (Glazier et al. 1992) . This increase in rat placental calbindin-D 9K expression is associated with a concomitant, stoichiometric increase in unidirectional maternofetal 45 Ca clearance over this period leading to the J Physiol 586.7 speculation that calbindin-D 9K may be rate limiting for placental calcium transport in this species (Glazier et al. 1992) . One of the fetal factors implicated in the regulation of placental calcium transport is parathyroid hormone-related protein (PTHrP), which is produced by the placenta as well as by other fetal tissues (Tobias & Cooper, 2004) . Although PTHrP was initially discovered as the humoral factor responsible for hypercalcaemia of malignancy, it is now known to have broad expression in a variety of fetal and adult tissues (reviewed in Philbrick et al. 1996) . The versatility of PTHrP in performing multiple, yet distinct, biological effects through endocrine, autocrine, paracrine and intracrine activities arises from alternative splicing of the PTHrP gene, giving rise to three initial translation products which then undergo post-translational processing to generate N-terminal, mid-region and C-terminal mature peptide fragments.
Consistent with this concept, calcium transfer into blood used to perfuse the fetal circulation of the in situ placenta in thyroparathyroidectomised fetal lambs was increased by the addition of partially purified hPTHrP or recombinant PTHrP(1-84), PTHrP(1-108) and PTHrP(1-141) but not by synthetic PTHrP(1-34) (Abbas et al. 1989) . This stimulation was rapid (within 1 h) and was also conferred by hPTHrP(67-86 amide) and hPTHrP(75-86 amide) fragments (Care et al. 1990) suggesting that this activity resides in the PTHrP(75-86) peptide sequence and that the N-terminus is not involved. By contrast, infusion of hPTHrP(1-34) or hPTHrP(75-86 amide) into the fetoplacental circulation of intact rat fetuses had no effect on the placental transport of calcium (Shaw et al. 1991) .
The availability of fetal mice homozygous for deletion of the PTHrP gene (PTHrP −/− null; NL) (Karaplis et al. 1994) has allowed closer examination of the effect of fetal PTHrP on placental calcium transport. NL fetuses exhibit abnormalities of endochondral bone development with accelerated endochondral ossification, yet, despite broad PTHrP tissue expression in PTHrP +/+ wild-type (WT) conceptuses, no gross morphological abnormalities were apparent in other tissues from NL fetuses (Karaplis et al. 1994) . In NL fetuses, fetal blood ionized Ca 2+ concentration is significantly reduced resulting in the abolition of the fetomaternal Ca 2+ gradient (Kovacs et al. 1996; Tucci et al. 1996) . The ratio of maternofetal transfer of 45 Ca normalized to that of 51 Cr-EDTA (used as a marker of diffusional permeability) was significantly reduced in NL fetuses when compared to WT and PTHrP +/− heterozygous (HZ) littermates (Kovacs et al. 1996) , suggesting dependence of Ca J mf on fetal PTHrP. Reversal of this effect by fetal injection 90 min before of hPTHrP(1-86) and hPTHrP(67-86), but not of hPTHrP(1-34), supports the concept that the mid-molecule region of PTHrP is functionally important in eliciting these acute effects. Curiously, in the light of these observations, others report a higher fetal calcium content in NL fetuses compared to WT littermates (Tucci et al. 1996) , suggesting that Ca J net is increased in the absence of fetal PTHrP. The explanation for these apparently divergent observations could be methodological, but may also reflect differences in the relative contribution of Ca J mf and/or Ca J fm to Ca J net . A more detailed examination of the role of fetal PTHrP on transplacental calcium fluxes is required.
To do this, we have developed a method in which the fetoplacental circulation is artificially perfused in situ in the mouse (Bond et al. 2006a ) allowing separate measurement of J mf and of fetoplacental calcium flux (J fp ) as an estimate of J fm . This technique provides a powerful tool to explore the molecular mechanisms involved in the regulation of unidirectional placental solute fluxes.
Methods

Chemicals
All chemicals were purchased from either Sigma-Aldrich Co. Ltd (Poole, UK) or VWR International (Lutterworth, UK) unless otherwise stated.
Animals
Experiments were performed in accordance with the UK Animals (Scientific Procedures) Act of 1986. PTHrP knockout mice generated by the targeted disruption in embryonic stem cells of exon IV, the major exon encoding mature murine PTHrP protein (Karaplis et al. 1994) , were a kind gift from Professor H. Kronenberg (Harvard Medical School, USA).
Females (8-12 weeks old) and males (6 weeks to 8 months old) heterozygous for the deleted PTHrP gene were mated and the first day of gestation determined by the discovery of a copulation plug (term, 19-20 days) . All animals were provided with nesting material and housed in cages maintained under a constant 12 h light-dark cycle at 21-23
• C with free access to food (Beekay Rat and Mouse Diet, Bantin & Kingman, Hull, UK) and tap water. At the end of the experiment, all animals were killed by Schedule 1 procedure in accordance with the UK Animals (Scientific Procedures) Act of 1986.
Fetuses were genotyped using genomic DNA extracted from fetal tail tips (DNeasy, Qiagen, Crawley, UK) with primers specific to gene sequences for PTHrP (sense, 5 -GCTACTGCATGACAAGGGCAAGTCC-3 ; antisense, 5 -GAGCCCTGCTGAACACAGTGAACAG-3 ) and neomycin resistance (sense, 5 -GGAGAGGCTAT-TCGGCTATGAC-3 ; antisense, 5 -CGCATTGCATCA-GCCATGATGG-3 ).
Placental calcium transfer studies
Measurement of unidirectional solute transfer across either the intact or perfused placenta is often expressed as solute clearance (Meschia et al. 1967) , a formulation without any underlying mechanistic assumptions (Sibley, 1994) . In the present investigation, unidirectional maternofetal clearance was measured both across perfused ( Ca K mf ) and intact ( Ca K mf(intact) ) placenta. Unidirectional fetoplacental clearance ( Ca K fp ) was measured using perfused placenta. Net flux ( Ca J net ) was calculated from calcium accretion rate in vivo. Unidirectional flux can be calculated as the algebraic product of unidirectional clearance and respective arterial concentration (Sibley, 1994) . across the perfused placenta Ca K mf across the perfused placenta of mice at 18 days of pregnancy (dp) was measured as previously described (Bond et al. 2006a) . The dam was anaesthetized with an intraperitoneal injection of 300 μl fentanyl/fluanisone (Hypnorm: Janssen Pharmaceutica, Belgium) and midazolam (Phoenix Pharma Ltd, Gloucester, UK) mixture (1 part fentanyl (0.315 mg ml −1 ) and fluanisone (10 mg ml −1 ), 1 part midazolam (5 mg ml −1 ), and 2 parts water). Additional doses of anaesthetic were given intraperitoneally (2-5 μl (g dam weight)
−1 ) during the course of the experiment as required.
Ca K mf was calculated (Sibley & Boyd, 1988) as:
where [v] is fetal side placental venous effluent radioisotope concentration (dpm μl −1 ), Q is the perfusion flow rate (μl min −1 ), W is the placental wet weight (g) and [A] is the maternal plasma radioisotope concentration (dpm μl −1 ) taken at the mid-point of the perfusate collection period by curvilinear interpolation from a pooled maternal 45 Ca disappearance curve (Bond et al. 2006a) . In these experiments, the dam was similarly prepared on 18 dp as detailed previously for the measurement of Ca K mf (Bond et al. 2006a) 
where [a] is the radioisotope concentration of arterial inflowing perfusate (dpm μl −1 ).
Inclusion criteria for perfusion experiments
Data were analysed from those experiments where (a) perfusate effluent recovery was 95% of perfusate inflow, (b) 45 CaCl 2 stock injectate radioactivity (dpm μl −1 ) fell within 95% of the mean value for all experiments, and (c) the radioisotope injection volume was within 10% of the 50 μl injectate volume. Inclusion criteria (b) and (c) were introduced to ensure that the radioactivity injected into each mouse was comparable thereby minimizing variability in the maternal radioisotope disappearance curve (Bond et al. 2006a) .
Unidirectional maternofetal clearance of 45 Ca across the intact placenta ( Ca K mf(intact) )
Ca K mf(intact) across the intact, unperfused placenta was measured on 18 dp using an adaptation of the method of Flexner & Pohl (1941) as previously described (Bond et al. 2006a) . Ca K mf(intact) was calculated as:
where, N x is total radiolabel accumulation (dpm) by the fetus (corrected for the fetal tail tip retained for genotyping) at x min after injection of radiolabel into the maternal vein and C m (t)dt is the time integral of radioisotope concentration in maternal plasma (dpm · min μl −1 ) from 0 to x min (taken from the maternal plasma 45 Ca disappearance curve; Bond et al. 2006a) .
Maternal plasma 45 Ca disappearance curve following injection into the maternal circulation
A maternal plasma 45 Ca disappearance curve was constructed from 78 dams at 18 dp and fitted to a one-phase exponential decay model (r 2 > 0.8) as previously described (Bond et al. 2006a) .
Net transplacental flux of calcium (
Ca J net )
Calcium content of fetal ash was measured at 17, 18 and 19 dp by atomic absorption spectrophotometry (Solaar J Physiol 586.7
S-Series, Thermo Elemental, Unicam Ltd, Cambridge, MA, USA) as previously described (Husain et al. 1994) . Tail tips were taken for genotyping as described above. Ca J net over 24 h (1440 min) between 17 to 18 or 18 to 19 dp was calculated as:
where W is mean placental wet weight (g) at either 18 or 19 dp, respectively.
Maternal whole blood ionized Ca 2+ concentration
Terminal blood samples, taken at 18 dp from the carotid artery following decapitation, were analysed for ionized Ca 2+ concentration (Bayer 865 Analyser, Siemens, Berkshire, UK).
Placental PTHrP expression
In order to assess the potential for endogenous placental production of PTHrP by maternal cells within decidua (Karperien et al. 1996) , PTHrP gene and protein expression were examined in fetuses from within the same litter. Paired fetal genomic DNA and placental cDNA from each genotype was amplified using exon IV-specific primers (sense, 5 -GTTTCTTCCTCCACCATCTG-3 ; antisense, 5 -ATCTGCCCTCATCGTCTG-3 ) and placental PTHrP protein expression was examined by immunohistochemistry (see below).
Western blotting
Individual placentas harvested at 18 dp were homogenized in buffer containing 300 mm mannitol, 12 mm Hepes (pH 7.6) and 1% protease inhibitor cocktail (Sigma-Aldrich) for 30 s. The homogenate was retained or centrifuged at 2500 g for 5 min at 4
• C (Sorvall Discovery 100SE, Kendro Laboratory Products, Bishop's Stortford, UK). Aliquots of this post-nuclear supernatant (PNS) were retained and the remaining PNS centrifuged at 100 000 g for 30 min at 4
• C to obtain the membrane fraction. Both fractions were analysed for protein concentration (Bio-Rad Protein Assay) and stored at −80
• C for further analysis.
Protein-SDS complexes were prepared with (Settle et al. 2004) or without (Bond et al. 2005 ) heat denaturation and SDS-PAGE performed followed by electrotransfer to nitrocellulose membranes (GE Healthcare, Little Chalfont, UK). The antisera used were rabbit polyclonal anti-human TRPV6 (ECaC2, 1 : 200; Santa Cruz Biotechnology, Insight Biotechnology, Wembley, UK), rabbit polyclonal anti-rat calbindin-D 9K (1 : 1000; SWANT, Bellizona, Switzerland), rabbit polyclonal anti-human plasma membrane calcium ATPase isoforms 1 (PMCA1) and 4 (PMCA4, 1 : 1000; SWANT), goat polyclonal anti-human PTHrP (1 : 200; Santa Cruz Biotechnology) and rabbit polyclonal anti-human β-actin (1 : 1000; Abcam, Cambridge, UK). Negative controls were prepared by omission of primary antibody or pre-absorption with excess blocking peptide. Immunoreactive species were detected with horseradish peroxidase-conjugated secondary antibodies (1 : 2000, Dako, Ely, UK) using an enhanced chemiluminescence detection system (GE Healthcare). Immunoreactive signal density was measured by densitometry (Bio-Rad Molecular Analyst) and all signals fell within the linear range of detection.
PTHrP immunohistochemistry
PTHrP immunohistochemistry was performed on sections (5 μm) of paraffin-embedded placentas using standard techniques after antigen retrieval by immersing slides in 0.01 m sodium citrate buffer pH 6 and microwaving on full power for 10 min. Non-specific binding was blocked with 10% rabbit serum. Goat polyclonal PTHrP antibody (2 μg ml −1 ; Santa Cruz) or non-immune goat IgG as negative control were applied overnight at 4
• C followed by incubation with biotinylated rabbit anti-goat IgG (1 : 100 Dako Ltd, UK) as secondary antibody. Sections were observed and photographed using a Leitz Dialux 22 microscope (Leica Microsystems, UK) and QICam 1394 digital camera (QImaging, UK).
Statistical analysis
All data are presented as mean ± s.e.m. where n is the number of fetuses/placentas. ANOVA with Bonferroni multiple comparison post hoc test was used to test the differences between experimental groups. Non-parametric comparisons were performed using Mann-Whitney and Kruskal-Wallis tests. P < 0.05 was taken as the significance level unless otherwise stated.
Abbreviations
PTHrP, parathyroid hormone-related protein; WT, wild-type; HZ, heterozygous; NL, null; TRPV, transient receptor potential vanilloid subfamily of calcium channels; ECaC, epithelial calcium channel; PMCA, plasma membrane Ca 2+ -ATPase; dp, day of pregnancy; PNS, postnuclear supernatant; IPYS, intraplacental yolk sac;
Ca K mf , unidirectional maternofetal clearance of calcium;
Ca K fp , unidirectional fetoplacental clearance of calcium;
Ca K mf(intact) , unidirectional maternofetal clearance of calcium across intact (unperfused) placenta; Ca J net , net flux of calcium to the fetus; Ca J mf , unidirectional maternofetal calcium flux;
Ca J fm , unidirectional fetomaternal calcium flux.
Results
Fetal and placental weight and fetal ionized Ca
2+ concentration
Placental and fetal weights, fetal : placental weight ratio and fetal blood ionized Ca 2+ concentration ([Ca 2+ ]) for WT, HZ and NL fetuses at 18 dp are given in Table 1 . Fetal weight was lower, and placental weight higher in NL fetuses compared to WT, with no difference with respect to other group comparisons. In the NL group, this was reflected in a significantly reduced fetal : placental weight ratio relative to HZ and WT groups.
[ Table 3 shows fetal calcium content for all genotypes at 17, 18 and 19 dp normalized to ash weight. Ash weight, unlike wet weight ( ( Table 3 ). The rise in Ca J net between day 18 and day 19 in NL fetuses was approximately double that for WT and HZ fetuses.
PTHrP gene expression
Placental cDNA from all three genotypes amplified PTHrP gene product (confirmed by sequencing) although product abundance appeared to be relatively lower in NL fetuses ( Fig. 1A) . However, no amplification product was visible in genomic DNA of NL fetuses (Fig. 1B) .
PTHrP immunohistochemistry
Figure 2 provides confirmation of the immunoreactive specificity of the anti-human PTHrP antibody for murine PTHrP and confirms negligible PTHrP protein expression in the placentas of NL fetuses. In placentas from WT and HZ fetuses, PTHrP immunoreactivity was intensely localized to the intraplacental yolk sac (IPYS) as well as being broadly distributed throughout the labyrinth trophoblast.
Expression of calcium transport proteins
Probing placental protein for calcium transport proteins that may mediate calcium epithelial influx (TRPV6/ECaC2; Fig. 3A ), cytosolic translocation (calbindin-D 9K ; Fig. 3B ) and efflux (PMCA1 and PMCA4; Fig. 3C and D) revealed immunoreactive signals of appropriate size for all proteins. Signal intensity was not significantly different across genotype for TRPV6, PMCA1 and PMCA4 (Fig. 3E) . However, in 7 of 9 litters examined calbindin-D 9K expression was higher in the placentas of NL fetuses compared to their WT and HZ littermates, as visible in Fig. 3B , with a mean increase in calbindin-D 9K expression of ∼37% ( Fig. 3E ; P < 0.07, Kruskal-Wallis test).
Discussion
In situ placental perfusion in the mouse (Bond et al. 2006a) has great potential as a methodology for measuring unidirectional clearances and fluxes in a species in which genetically modified strains are widely available. A striking finding of this study (Table 3) is the concordance between transport measurements for an actively transported solute, calcium, obtained in three ways: across fetal-side perfused placenta; across unperfused in situ placenta in anaesthetized animals; and in vivo. These observations therefore provide considerable confirmatory confidence in this methodology.
The values of Ca K mf per unit placental weight obtained here and our demonstration that calcium flux across the mouse placenta is highly asymmetric, with Ca J mf prevailing and approaching Ca J net , accord with previous observations in the rat (Štulc &Štulcová, 1986; Mughal et al. 1989; Robinson et al. 1989) . Also, the very low ratio of Ca K fm to Ca K mf is consistent with that found in the rat (Štulc & Stulcová, 1986 ) and, to a lesser degree, in women (Štulc et al. 1994) .
The phenotype of PTHrP-null mutants, a domed skull, short snout and mandible with protruding tongue and shortened limbs (Karaplis et al. 1994) , were clearly discernible at 18 dp. In such mutants, PTHrP allele expression was confirmed to be absent using primers to exon IV, the major exon encoding murine PTHrP. The reduction of ∼6% in the weight of PTHrP-null fetuses is consistent with previous observations (Kovacs et al. 2001) although others report a similar body weight at birth (Karaplis et al. 1994) . The efficiency of placental nutrient transfer may be attenuated in NL fetuses as evidenced by the reduced fetal : placental weight ratio.
In agreement with previous observations (Kovacs et al. 1996; Tucci et al. 1996) , PTHrP-null mutants had a significantly lower fetal blood ionized Ca 2+ concentration resulting in abolition of the fetomaternal Ca 2+ concentration gradient. In contrast, fetal blood ionized Ca 2+ concentration in WT and HZ fetuses was comparable and significantly higher than maternal Ca concentration, also demonstrated previously (Kovacs et al. 1996; Tucci et al. 1996) .
Previous studies have demonstrated a broad distribution of PTHrP mRNA and immunoreactivity in mouse placenta, being particularly abundant in the IPYS which lines the sinus of Duval connecting the yolk sac and the uterine lumen, but also detected in the labyrinth trophoblast (Kovacs et al. 2001 (Kovacs et al. , 2002 , as observed here. As expected, PTHrP immunoreactivity was undetectable in the placental labyrinth of NL fetuses consistent with previous observations (Kovacs et al. 2001 (Kovacs et al. , 2002 . We infer that PTHrP gene transcription in the placenta of NL fetuses (Fig. 1) arises from maternal cellular components of decidua (Karperien et al. 1996) although decidual PTHrP immunoreactivity in placenta from NL fetuses was undetectable (data not shown), suggesting paracrine effects of maternally derived PTHrP on placental function can be discounted.
Our starting hypothesis was that Ca J mf would be down-regulated in placentas of NL fetuses based on . For all blots the immunoreactive species detected accord with the predicted molecular mass of the target protein, with signal abolished by omission of primary antibody (not shown). E, densitometric analysis (mean + S.E.M.) of immunoreactive signal intensity for TRPV6 (ECaC2; n = 6), calbindin-D 9K (n = 9), PMCA1 (n = 6) and PMCA4 (n = 6) in placentas of WT, HZ and NL fetuses. Mean calbindin-D 9K expression in NL fetuses was ∼37% higher than in WT and HZ littermates (P < 0.07, Kuskal-Wallis). All signals fell within the linear range of detection. For PMCA1 and PMCA4 signals comprising the triplet and doublet species, respectively, were analysed collectively. Equal protein loading was confirmed by densitometric analysis of replicate blots probed for β-actin (data not shown).
previous evidence from PTHrP knockout mice (Kovacs et al. 1996) and studies examining the acute effects of PTHrP administration (outlined in the introduction). However, in contrast, our observations are all consistent in showing that calcium transport across the placenta of the NL fetus is, in fact, up-regulated. This assertion is based on the following evidence: (a) Ca K mf was significantly elevated across the perfused placenta of the NL fetus compared to WT and HZ littermates, and at a significance level of P < 0.07 across the intact placenta (Table 2) ; (b) in the NL group there was a significant increase in fetal calcium accretion by day 19 of gestation consistent with an increased Ca J net (Table 3) ; (c) the very low and similar values of Ca K fp in all genotypes (Table 2 ) implies different fetomaternal fluxes beween genotypes cannot account for (b); and (d) placental expression of calbindin-D 9K , a molecular marker of placental calcium flux (Glazier et al. 1992 ) that predicts fetal calcium content (Verhaeghe et al. 1999) , is probably raised (P < 0.07) in NL fetuses compared to WT and HZ littermates (Fig. 3) .
Our previous flux measurements in the mouse implicate active calcium transport mechanisms (Bond et al. 2006a) , compatible with our demonstration and that of others (Kovacs et al. 2002) that calcium transport proteins mediating influx (TRPV6; ECaC2), transcytosolic movement (calbindin-D 9K ) and efflux (PMCA) are co-expressed in mouse placenta. Of these, expression of calbindin-D 9K appears, as noted previously (Kovacs et al. 2002) , to be specifically altered by a lack of fetal PTHrP.
The up-regulation in calbindin-D 9K expression parallels the increase in Ca K mf , as in the rat where placental calbindin-D 9K expression and Ca K mf change in concert (Glazier et al. 1992; Husain et al. 1994) . The cellular location of this altered calbindin-D 9K expression remains uncertain, as a variety of cell types other than the labyrinth within the murine placenta express calbindin-D 9K with a predominant localization to the IPYS (Mathieu et al. 1989; Ogura et al. 1998; Verhaeghe et al. 1999; Kovacs et al. 2002 Kovacs et al. , 2005 Rummens et al. 2003) . This distribution of calbindin-D 9K to the IPYS, along with a host of other calcitropic hormones and receptors (Kovacs et al. 2002 (Kovacs et al. , 2005 , has led to the proposal that the IPYS, a unique structure restricted to rodent placentas and formed by invagination of the primitive yolk sac into the chorioallantoic placenta (Ogura et al. 1998) , provides a potential pathway for maternofetal calcium transfer in addition to exchange across the labyrinth trophoblast (Kovacs et al. 2002) . However, the measurements of Ca K mf made here do not allow relative contribution of these pathways to be addressed. Mutant mice lacking an IPYS (Ogura et al. 1998 ) may be useful in examining this issue further.
The collective evidence presented here supports the notion that maternofetal calcium transport by the placenta of NL fetuses is increased compared to WT and HZ littermates. This contrasts with the conclusions of Kovacs et al. (1996 Kovacs et al. ( , 2001 Kovacs et al. ( , 2002 . They found diminished placental calcium transport across the intact placenta, normal fetal calcium content and reduced placental calbindin-D 9K expression. However, there were several methodological differences between the two studies which might contribute to this disparity including: (a) the route, volume and amount of 45 Ca tracer (intracardiac, 100 μl, 50 μCi 45 Ca); (b) gestational age (17 dp); (c) anaesthetic (isoflurane inhalation); and (d) incorporation of 51 Cr-EDTA (50 μCi) as a paracellular marker with data expressed as 45 Ca/ 51 Cr ratio. A change in the 45 Ca/ 51 Cr ratio as an index of calcium transport by Kovacs et al. (1996) allows for the possibility that either the numerator or denominator is altered. Related to this, we have previously shown that the maternofetal clearance of 14 C-mannitol (a hydrophilic tracer with a similar diffusion coefficient in water to calcium) is significantly lower in the NL relative to its HZ and WT counterparts (Bond et al. 2006b ), making interpretation following normalization to a paracellular marker under these circumstances a potential major source of error.
The interrelationships between fetal calcium homeostasis, placental calcium transport and fetal skeletal mineralization are complex, reliant upon the co-ordinated action of PTHrP and PTH (Tobias & Cooper, 2004; Miao et al. 2002) . Fetal mice in which PTHrP or the PTHR1 gene is ablated or which lack parathyroid glands and so are unable to produce PTH (Hoxa3), all exhibit fetal hypocalcaemia, but show disparate patterns with regard to placental calcium transport, fetal PTH/PTHrP plasma concentration or fetal calcium accretion (Kovacs et al. 2001) . This serves to emphasize that fetal calcaemia reflects the composite dynamics of calcium flux across both the placenta and fetal bone, calcium excretion by fetal kidney and its movement to and from amniotic fluid. The latter pathway is unlikely to confound the observations presented here as amniotic fluid calcium concentration is unaltered in NL fetuses (Kovacs et al. 2001) .
The critical role of PTHrP in fetal skeletal morphogenesis is well established, acting in a paracrine manner to stimulate the proliferation of chondrocytes and delay their maturation (Karaplis et al. 1994; Miao et al. 2002; Tobias & Cooper, 2004) . Derangement of this process by the targeted disruption of the PTHrP gene leads to lethal dyschondroplasia, premature differentiation of chondrocytes and advanced mineralization of the endochondral skeleton. This skeletal dysmorphogenesis is apparent as early as 14.5 days of gestation (Karaplis et al. 1994) , a time at which PTHrP/PTH receptor expression is up-regulated in proliferating chondrocytes (MacLean & Kronenberg, 2005) . Our demonstration that a lack of fetal PTHrP is associated with enhanced skeletal calcium deposition is compatible with the excessive skeletal mineralization and premature calcification/ossification found in NL fetuses (Karaplis et al. 1994) and agrees well with the observations of Tucci et al. (1996) . In contrast, Kovacs et al. (2001) demonstrated comparable calcium content between genotypes, perhaps surprising in view of the excessive skeletal mineralization of NL fetuses. This excessive skeletal mineralization of the PTHrP-null mutant raises the possibility of an elevated fetal calcium demand, which we reason stimulates maternofetal calcium transport by a mechanism independent of fetal PTHrP, probably involving increased expression of calbindin-D 9K .
The regulatory stimuli involved in evoking this calbindin-D 9K response remain unclear. Fetal hypocalcaemia seems an unlikely candidate based on the lack of correspondence between placental calbindin-D 9K expression which is reduced or unchanged in the face of fetal hypocalcaemia (Kovacs et al. 2001 (Kovacs et al. , 2002 (Glazier et al. 1995; Rummens et al. 2003; Kovacs et al. 2005) argue against its direct J Physiol 586.7 involvement. A significant elevation in fetal serum PTH in both PTHrP-and PTHR1-null fetuses (Kovacs et al. 2001) is not associated with a consistent trend in calbindin-D 9K expression (Kovacs et al. 2002) suggesting a lack of direct regulation by PTH. Additionally PTH (1-84) had no effect on Ca K mf across the placenta of intact rat fetuses (Robinson et al. 1989) . Multiple regulatory factors may be involved in the trend to an altered placental calbindin-D 9K expression observed here.
In summary, this study provides clear evidence of increased maternofetal calcium transport across the placenta of PTHrP-null fetuses with increased fetal calcium accretion despite pronounced fetal hypocalcaemia and abolition of the fetomaternal calcium gradient. The asymmetric nature of this response is indicated by the lack of effect on Ca K fp . In situ placental perfusion of the mouse placenta provides a valuable tool to examine the regulation of unidirectional placental calcium flux, providing mechanistic insights regarding the role of fetal PTHrP.
